Joseph Sinkule serves as Executive at Klotho Neurosciences, Inc., where they oversee executive responsibilities. Since joining the company, Joseph Sinkule has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 25, 2025 involved transacting 400,000 shares valued at $0.
Joseph Sinkule currently holds 4,846,700 shares of Klotho Neurosciences, Inc. (KLTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Sinkule has been a net neutral trader of KLTO stock. They have purchased $0 and sold $0 worth of shares.
Joseph Sinkule's most recent insider trade was on Sep 25, 2025, when they sold 400,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 22, 2025 | KLTO | $0 | Other | 2,000,000 | $N/A | Discretionary |